• Login
    View Item 
    •   Vlerick Repository Home
    • Business Research Projects
    • In-Company Projects (ICPs)
    • View Item
    •   Vlerick Repository Home
    • Business Research Projects
    • In-Company Projects (ICPs)
    • View Item
    JavaScript is disabled for your browser. Some features of this site may not work without it.

    Browse

    All of Vlerick RepositoryCommunities & CollectionsPublication DateAuthorsTitlesSubjectsKnowledge Domain/IndustryThis CollectionPublication DateAuthorsTitlesSubjectsKnowledge Domain/Industry

    My Account

    LoginRegister

    Contact & Info

    ContactVlerick Journal ListOpen AccessVlerick Business School

    Statistics

    Display statistics

    The post-merger integration of biotechs by a pharmaceutical firm

    • CSV
    • RefMan
    • EndNote
    • BibTex
    • RefWorks
    Author
    Heyrman, Pascal
    Lenfant, Harold
    Supervisor
    Haspeslagh, Philippe
    Publication Year
    2022
    Publication Number of pages
    122
    
    Metadata
    Show full item record
    Abstract
    Pharmaceutical industry remains one of the largest sectors for M&A. Pharmaceutical companies are active in M&A, searching for new sources of competitive advantage and growth. In the last few years, the focus of big pharmaceutical companies has shifted from the so-called mega-mergers, to targeting acquisitions of smaller companies that support their research and development (“R&D”) activities. Often these are biotechnological companies, that derive drugs not from chemicals, but from extraction or manipulation of living organisms. In this context, UCB has acquired several spin-offs emerging from innovative ecosystems over the past years. To create value, these biotechnological companies must be nurtured and integrated through a post-merger integration process (“PMI”). To guide this process, UCB created a Post-Merger Integration playbook. It captures the industry’s best practices along with UCB’s own learnings from some recent acquisitions, distilled into an overview of the key steps and considerations for delivering a successful program. However, this playbook does not consider some of the research specificities that are inherent to research-driven entities like biotech. The goal of the project is to identify the recurrent issues and capture them into guidelines or adjusted processes, to ensure that research-based acquisitions will be integrated smoothly in the future. To identify these recurrent issues, a thorough case study was made of three research-based acquisitions made by UCB: Element Genomics, Ra Pharmaceuticals and Handl Therapeutics. To develop these case studies, 40 interviews were conducted with employees both from UCB and the acquired entities. With the information gained from these interviews, a narration as well as an analysis of the integration of the three past acquisitions was made. From this analysis, patterns of acquisition motives were identified. The theory regarding integration models was developed and transposed to the case study, with variations. Finally, a grouping of cultural and organizational challenges was presented and a set of specific recommendations for future integrations was developed.
    Knowledge Domain/Industry
    Entrepreneurship
    URI
    http://hdl.handle.net/20.500.12127/7216
    Collections
    In-Company Projects (ICPs)

    entitlement

     
    DSpace software (copyright © 2002 - 2023)  DuraSpace
    Quick Guide | Contact Us
    Open Repository is a service operated by 
    Atmire NV
     

    Export search results

    The export option will allow you to export the current search results of the entered query to a file. Different formats are available for download. To export the items, click on the button corresponding with the preferred download format.

    By default, clicking on the export buttons will result in a download of the allowed maximum amount of items.

    To select a subset of the search results, click "Selective Export" button and make a selection of the items you want to export. The amount of items that can be exported at once is similarly restricted as the full export.

    After making a selection, click one of the export format buttons. The amount of items that will be exported is indicated in the bubble next to export format.